Tumor cell fragments activate MAPK signaling pathways through Vγ9Vδ2TCR, up-regulate the expression of scavenger receptor CD36, enhance antigen uptake and processing of Vγ9Vδ2 T cells, and then induced tumor antigen-specific CD8+T cell response (136). Here, CD8A is linked to neoplasm.